The LYNX labels are covalently and directionally conjugated to the user's antibody in a controlled process at near neutral pH, requiring no subsequent desalting steps. This offers significant advantages over traditional labeling methods needing subsequent sample concentration and dialysis, where antibody loss is a risk and batch-to-batch consistency for experiments cannot be guaranteed.
Whether conjugating microgram or milligram quantities of antibody, the hands-on time using LYNX Kits remains 30 seconds. Therefore a researcher can trial-run conjugated antibodies, and optimize their application protocols on the small scale before easily scaling up. To complement this, LYNX Rapid Conjugation Kits are available in a number of cost-effective pack sizes for Alkaline Phosphatase, Allophycocyanin, Biotin, Glucose Oxidase, Horseradish Peroxidase, and R-Phycoerythrin.
For more information, visit www.ab-direct.com/lynx.
About AbD Serotec: AbD Serotec is the research antibody division of MorphoSys, one of the world's leading human antibody technology companies with sales offices in Germany (Munich), the U.S. (Raleigh, NC), the U.K. (Oxford) and France. AbD Serotec's comprehensive product catalog comprises more than 10,000 research antibodies and immunology reagents guaranteed to perform to specification, with the majority in stock for next-day shipping. Custom monoclonal antibodies for research applications can be generated in just 8 weeks using fully recombinant HuCAL technology from MorphoSys. Additionally, AbD Serotec offers ISO-certified large-scale antibody production and a range of customized services including antibody conjugations for end-users and OEM customers. A comprehensive metasearch of the entire AbD Serotec range of re! ady-made antibodies can be performed at www.ab-direct.com.
